Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5940101 | The American Journal of Pathology | 2010 | 13 Pages |
Abstract
We used mast cell-engrafted genetically mast cell-deficient C57BL/6-KitW-sh/W-sh mice to investigate the roles of mast cells and mast cell-derived tumor necrosis factor in two models of severe bacterial infection. In these mice, we confirmed findings derived from studies of mast cell-deficient WBB6F1-KitW/W-v mice indicating that mast cells can promote survival in cecal ligation and puncture (CLP) of moderate severity. However, we found that the beneficial role of mast cells in this setting can occur independently of mast cell-derived tumor necrosis factor. By contrast, using mast cell-engrafted C57BL/6-KitW-sh/W-sh mice, we found that mast cell-derived tumor necrosis factor can increase mortality during severe CLP and can also enhance bacterial growth and hasten death after intraperitoneal inoculation of Salmonella typhimurium. In WBB6F1-KitW-sh/W-sh mice, mast cells enhanced survival during moderately severe CLP but did not significantly change the survival observed in severe CLP. Our findings in three types of genetically mast cell-deficient mice thus support the hypothesis that, depending on the circumstances (including mouse strain background, the nature of the mutation resulting in a mast cell deficiency, and type and severity of infection), mast cells can have either no detectable effect or opposite effects on survival during bacterial infections, eg, promoting survival during moderately severe CLP associated with low mortality but, in C57BL/6-KitW-sh/W-sh mice, increasing mortality during severe CLP or infection with S. typhimurium.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Adrian M. Piliponsky, Ching-Cheng Chen, Michele A. Grimbaldeston, Stacy M. Burns-Guydish, Jonathan Hardy, Janet Kalesnikoff, Christopher H. Contag, Mindy Tsai, Stephen J. Galli,